Cost-effectiveness of introducing a rotavirus vaccine in developing countries: The case of Mexico
Open Access
- 29 July 2008
- journal article
- Published by Springer Science and Business Media LLC in BMC Infectious Diseases
- Vol. 8 (1), 103
- https://doi.org/10.1186/1471-2334-8-103
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Efficacy of a pentavalent rotavirus vaccine in reducing rotavirus-associated health care utilization across three regions (11 countries)International Journal of Infectious Diseases, 2007
- Diarrhea Morbidity and Mortality in Mexican ChildrenThe Pediatric Infectious Disease Journal, 2004
- Hospitalisations for gastroenteritis: the role of rotavirusVaccine, 2004
- Rotavirus Diarrhea Severity Is Related to the VP4 Type in Mexican ChildrenJournal of Clinical Microbiology, 2003
- Global Illness and Deaths Caused by Rotavirus Disease in ChildrenEmerging Infectious Diseases, 2003
- Epidemiology of Acute Viral Gastroenteritis in Children Hospitalized in Rouen, FranceClinical Infectious Diseases, 2002
- Pronóstico de la diarrea por rotavirusSalud Publica de Mexico, 2001
- Rotavirus Infection in Infants as Protection against Subsequent InfectionsThe New England Journal of Medicine, 1996
- Acquisition of Serum Antibody to Norwalk Virus and Rotavirus and Relation to Diarrhea in a Longitudinal Study of Young Children in Rural BangladeshThe Journal of Infectious Diseases, 1982
- Clinical features of acute gastroenteritis associated with human reovirus-like agent in infants and young childrenThe Journal of Pediatrics, 1977